EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis Patients

Davide Bolignano, Marta Greco, Sara Pugliese, Anila Duni, Pierangela Presta, Antonietta Errante, Efthymios Pappas, Lampros Lakkas, Roberta Misiti, Katerina K Naka, Daniela Patrizia Foti, Michele Andreucci und 2 weitere

Cardiorenal Medicine · 18.03.2026 · 16 (1) · 179-189

DOI: 10.1159/000551517 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiorenal Medicine, online erschienen am 18.03.2026. Verfasst von Davide Bolignano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy, davide.bolignano@gmail.com. Hauptthemen laut MEDLINE: Renal Dialysis, Kidney Failure, Chronic, Cardiovascular Diseases, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiovascular morbidity and mortality (CVMM) remain highly prevalent among end-stage kidney disease (ESKD) patients undergoing chronic hemodialysis (HD). Nevertheless, risk prediction in this setting is limited by the complexity of factors involved and the individual patients’ characteristics. In this study, we evaluated whether circulating levels of Humanin, a micropeptide reflecting mitochondrial dysfunction, could refine CVMM prediction when included in established risk models for CVMM in ESKD-HD.

Methods

Eighty-three chronic HD patients (mean age 67 ± 12 years; 74.7% male) were enrolled in a 24-month prospective multicenter study. CVMM (fatal or non-fatal CV events requiring hospitalization) occurred in 33 patients (39.7%). The performances of an internal prognostic model based on cohort-related risk predictors and four externally generated and validated risk scores (AROii-2, jDOPPS, You et al., and Zhang et al.) were compared before and after the inclusion of Humanin.

Results

Humanin displayed a curvilinear association with CVMM, with both low (778 pg/mL) levels linked to an increased risk. CVMM was best predicted by the internal model (AUC 0.671; R2 0.13), followed by the Zhang (0.669; 0.12), AROii-2 (0.632; 0.05), You (0.628; 0.07), and jDOPPS (0.610; 0.03) scores. All models were well calibrated. Humanin inclusion remarkably improved discrimination (ΔAUC spanning from 0.083 to 0.109), calibration, explained variance (R2 gain from 9 to 15%), and reclassification (Net Reclassification Improvement: 8–27.9%; Integrated Discrimination Index: 4.4–7.3%) of all models considered.

Conclusions

Integration of Humanin significantly enhances the predictive accuracy of CVMM risk models in HD patients, supporting its potential role as an additive biomarker in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisKidney Failure, ChronicCardiovascular DiseasesIntracellular Signaling Peptides and ProteinsHumansMaleAgedFemaleProspective StudiesPrognosisBiomarkersRisk AssessmentMiddle AgedRisk Factors

Stichwörter der Autor:innen

Cardiovascular riskEnd-stage kidney diseaseHemodialysisHumanin

Substanzen

BiomarkershumaninIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Nephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy, davide.bolignano@gmail.com.
  • Department of Medical and Surgical Sciences-Renal Unit, University "Magna Graecia", Campus Salvatore Venuta, Catanzaro, Italy, davide.bolignano@gmail.com.
  • Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
  • Clinical Pathology Lab, Magna Graecia University, Catanzaro, Italy.
  • Nephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.
  • Department of Nephrology, School of Medicine, University of Ioannina, Ioannina, Greece.

Zitieren

APA

Bolignano, D., Greco, M., Pugliese, S., Duni, A., Presta, P., Errante, A., Pappas, E., Lakkas, L., Misiti, R., Naka, K. K., Foti, D. P., Andreucci, M., Coppolino, G., & Dounousi, E. (2026). Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis Patients. Cardiorenal Medicine, 16(1), 179-189. https://doi.org/10.1159/000551517

Vancouver

Bolignano D, Greco M, Pugliese S, Duni A, Presta P, Errante A, et al. Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis Patients. Cardiorenal Medicine. 2026;16(1):179-189. doi:10.1159/000551517

BibTeX
@article{Bolignano2026,
  author = {Bolignano, Davide and Greco, Marta and Pugliese, Sara and Duni, Anila and Presta, Pierangela and Errante, Antonietta and Pappas, Efthymios and Lakkas, Lampros and Misiti, Roberta and Naka, Katerina K and Foti, Daniela Patrizia and Andreucci, Michele and Coppolino, Giuseppe and Dounousi, Evangelia},
  title = {Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Risk Models in Chronic Hemodialysis Patients},
  journal = {Cardiorenal Medicine},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {179--189},
  doi = {10.1159/000551517}
}
Kostenlos starten →